CXCR4 and HIV-1 infection: By combining a CRISPR-Cas9 strategy and piggyBac transposon system, we achieved efficient replacement of wild-type CXCR4 with a CXCR4 P191A homozygous mutant in an HIV-1 reporter cell line and observed significant inhibition of HIV-1 infection.